Eli Lilly and Co
(MIL:1LLY)
€
733.1
-11.4 (-1.53%)
Market Cap: 703.72 Bil
Enterprise Value: 729.10 Bil
PE Ratio: 87.15
PB Ratio: 50.94
GF Score: 66/100 
Eli Lilly and Co at Leerink Partners Global Healthcare Conference Transcript
Feb 27, 2019 / 06:00PM GMT
James Arthur Kelly
SVB Leerink LLC, Research Division - Associate Director of Research
Okay, good, afternoon everybody. We're going to get going on our next fireside chat. So I'm Jim Kelly, I'm the Associate Director of Research. And I'm really pleased to be joined here by Christi Shaw from Eli Lilly. She's the President of their Bio-Medicines group, which focus principally on the immunology and the neurology segment. And thank you so much for joining us today and joining the conference.
Christi Shaw
Eli Lilly and Company - Senior VP & President of Lilly Bio-Medicines
Thanks for having me.
Questions & Answers
James Arthur Kelly
SVB Leerink LLC, Research Division - Associate Director of Research
Absolutely. What I'd like to do, Christi...
Christi Shaw;James Arthur Kelly
Eli Lilly and Company - Senior VP & President of Lilly Bio-Medicines;SVB Leerink LLC, Research Division - Associate Director of
This is on, right? Yes.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers